SG

Sam Goldberger

Managing Partner at Ambit Health Ventures

Greater Boston

Overview 

Sam Goldberger is the Managing Partner at Ambit Health Ventures in Greater Boston, specializing in strategic M&A, early stage investments, and board-level expertise in the healthcare industry. With a background in clinical research and medicine, Sam has successfully invested in companies like Smartlens and SOAP Health, contributing to their growth and development.

Work Experience 

  • Member Board of Directors

    2023 - Current

SurgiBox develops an operating room in a backpack system that makes surgery safer for patients and providers at any time and any place.

Raised $3,525,000.00 from Medical Technology Enterprise Consortium, TechConnect World Innovation Conference & Expo and MassChallenge.

  • Managing Partner and Co-Founder

    2020

    Ambit Health Ventures is a boutique healthcare innovation venture capital firm focused on investments in early-stage digital health firms. Our leaders have extensive experience in these sectors. Our aim is to improve healthcare through our portfolio companies’ innovation while achieving financial gain for our investors.

Ambit Health Ventures is a healthcare venture capital firm that focuses on investments in early-stage digital health and MedTech firms.

  • Member Board of Directors

    2023

Clinical stage, novel technologies for managing Glaucoma

Raised $6,100,000.00 from Sophia Innovation Capital, Ambit Health Ventures, Stanford University, WS Investments, Graphene Ventures, Plaisance Capital Management, 3E Bioventures and Boutique Venture Partners.

  • Member Board of Directors

    2022

SOAP's patented, clinically validated, AI powered patient intake combines early disease risk and symptom assessment to improve diagnosis

Raised $3,400,000.00 from Ambit Health Ventures, Mayo Clinic Platform, Jumpstart Foundry and Right Side Capital Management.

  • Member Board Of Directors

    2021

  • Board Observer, BRAINBox Solutions, Inc

    2021

BRAINBox provides objective evidence of injury and prediction of patient recovery.

Raised $39,502,735.00 from Genoa Ventures.

  • Board Observer, Smartlens

    2021 - 2022

Clinical stage, novel technologies for managing Glaucoma

Raised $6,100,000.00 from Sophia Innovation Capital, Ambit Health Ventures, Stanford University, WS Investments, Graphene Ventures, Plaisance Capital Management, 3E Bioventures and Boutique Venture Partners.

  • Senior Clinical Monitor and Strategic Advisor

    2016 - 2021

Privo Technologies is a development-stage biotechnology company located just outside Boston, MA.

Raised $5,684,934.00 from National Cancer Institute, National Institute of Dental and Craniofacial Research (NIDCR), National Science Foundation and MassChallenge.

  • CEO

    2018 - 2020

    Sourced, performed due diligence, and invested in early stage healthcare companies.

  • CEO

    2016 - 2018

    CEO of operating company for a PE backed ophthalmology and eyecare roll-up.

Articles About Sam

Relevant Websites